Tokyo - Delayed Quote JPY

Eisai Co., Ltd. (4523.T)

Get top stock picks
4,030.00
-24.00
(-0.59%)
At close: 3:30:00 PM GMT+9
Get top stock picks
Currency in JPY All numbers in thousands
Download
Breakdown
TTM
3/31/2025
3/31/2024
3/31/2023
3/31/2022
Total Revenue
789,400,000
789,400,000
741,751,000
744,402,000
756,226,000
Cost of Revenue
168,807,000
168,807,000
155,333,000
177,837,000
174,831,000
Gross Profit
620,593,000
620,593,000
586,417,000
566,566,000
581,395,000
Operating Expense
566,216,000
566,216,000
533,010,000
526,526,000
527,645,000
Operating Income
54,377,000
54,377,000
53,407,000
40,040,000
53,750,000
Net Non Operating Interest Income Expense
6,688,000
6,688,000
8,416,000
4,973,000
709,000
Pretax Income
61,065,000
61,065,000
61,823,000
45,012,000
54,458,000
Tax Provision
13,007,000
13,007,000
18,040,000
-11,824,000
8,741,000
Net Income Common Stockholders
46,432,000
46,432,000
42,406,000
55,432,000
47,954,000
Diluted NI Available to Com Stockholders
46,432,000
46,432,000
42,406,000
55,432,000
47,954,000
Basic EPS
163.76
163.76
147.86
193.31
167.27
Diluted EPS
163.76
163.76
147.86
193.31
167.25
Basic Average Shares
283,536.88
283,536.88
286,798.32
286,757
286,685
Diluted Average Shares
283,536.88
283,536.88
286,798.32
286,761
286,729
Total Operating Income as Reported
54,378,000
54,378,000
53,408,000
40,040,000
53,750,000
Total Expenses
735,023,000
735,023,000
688,343,000
704,363,000
702,476,000
Net Income from Continuing & Discontinued Operation
46,433,000
46,433,000
42,407,000
55,432,000
47,954,000
Normalized Income
46,433,000
46,433,000
42,407,000
55,432,000
47,954,000
Interest Income
10,207,000
10,207,000
10,804,000
7,239,000
2,401,000
Interest Expense
3,519,000
3,519,000
2,388,000
2,266,000
1,692,000
Net Interest Income
6,688,000
6,688,000
8,416,000
4,973,000
709,000
EBIT
64,584,000
64,584,000
64,211,000
47,278,000
56,150,000
EBITDA
104,490,000
104,490,000
103,609,000
87,259,000
94,548,000
Reconciled Cost of Revenue
168,807,000
168,807,000
155,333,000
177,837,000
174,831,000
Reconciled Depreciation
39,906,000
39,906,000
39,398,000
39,981,000
38,398,000
Net Income from Continuing Operation Net Minority Interest
46,433,000
46,433,000
42,407,000
55,432,000
47,954,000
Normalized EBITDA
104,490,000
104,490,000
103,609,000
87,259,000
94,548,000
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
0
3/31/2022 - 1/4/2000

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

4530.T Hisamitsu Pharmaceutical Co., Inc.
4,298.00
-1.17%
 
DPM.MU Sumitomo Pharma Co Ltd
6.10
-0.81%
 
4507.T Shionogi & Co., Ltd.
2,508.50
+0.91%
 
4506.T Sumitomo Pharma Co., Ltd.
1,047.00
-1.04%
 
EAPH Parallel Industries Inc.
0.0001
+900.00%
 
HLUN-A.CO H. Lundbeck A/S
31.30
-1.42%
 
PCRX Pacira BioSciences, Inc.
24.34
+0.41%
 
ALKS Alkermes plc
29.42
-1.37%
 
CPIX Cumberland Pharmaceuticals Inc.
5.48
+4.58%
 
HLUN-B.CO H. Lundbeck A/S
38.46
-1.89%